IBIO123
Indication: COVID-19
Target: SARS-CoV-2
Development Partner: Seeking
STAGE
Discovery
100%
Pre-Clinical
100%
Phase 1
100%
Phase 2
100%
IBIO201
Indication: Coronaviruses
Target: All coronaviruses
Development Partner: Seeking
STAGE
Discovery
85%
Pre-Clinical
0%
Phase 1
0%
Phase 2
0%
IBIO301
Indication: Immuno-oncology
Target: LILRB1/2
Development Partner: Seeking
STAGE
Discovery
85%
Pre-Clinical
0%
Phase 1
0%
Phase 2
0%
IBIO401
Indication: Pediatric Leukemia
Target: HLA-Associated
Development Partner: Partnered, Undisclosed
STAGE
Discovery
85%
Pre-Clinical
0%
Phase 1
0%
Phase 2
0%
